Montana’s plan to become an experimental medical hub are moving forward
MIT Technology Review Narrated

Montana’s plan to become an experimental medical hub are moving forward

B2Upper-intermediateAugust 12, 202617 min

The state’s effort to expand the “right to try” is making headway, and the first drugs are about to be reviewed. This story was written by Jessica Hamzelou and narrated by Noa - newsoveraudio.com. Listen to more of the world's best journalism on the Noa app.

Play episode

Opens the player: the full transcript, every word clickable, with translation and flashcards.

Try it: tap any word

Real sentences from the start of this episode. Every word is marked with its level.

Sentence 5 of 12 · 0:30

Here's this week's story. I hope you enjoy it.

,

forward.

Hear this sentence

Tap a word to see its meaning in your language.

Do you know these words?

8 harder words from this episode. Tap one to see what it means, then mark it.

  • B20:30
  • B22:15
  • B24:19
  • B27:25
  • B210:13
  • B210:44
  • C112:34
  • B214:31

Mark a few words and we'll tell you how this episode fits your level.

Is this episode right for you?

B2

B2 · Upper-intermediate

Comfortable if you already follow TV news

A1 8%A2 29%B1 36%B2 20%C1 7%
  • 73% of the words are B1 or easier.
  • 134 words a minute: a natural pace.
  • 124 harder words (B2 and up) in the whole episode.

Transcript

The opening of the episode. The whole transcript is in the player.

0:00

Welcome to MIT Technology Review Narrated. My name is Matt Honin. I'm our Editor-in-Chief. Every week, we'll bring you a fascinating, new, in-depth story from the leading edge of science and technology, covering topics like AI, biotech, climate, energy, robotics, and more. Here's this week's story. I hope you enjoy it.

0:30

Jessica Hamzalu writes, Montana's plan to become an experimental medical hub just pushed forward. As of July 2026 in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers.

0:51

Companies whose drugs have been through preliminary testing, sometimes in as few as 10 healthy people can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the company can set the price of the drug and sell it via experimental treatment clinics, the first of which is likely to be up and running around

That was the opening. The rest of the episode (16 min) is in the player: every word clickable, with translation, saved words and flashcards.

Continue in the player

Automatically generated from the audio. May contain errors. Audio belongs to its publisher and is played from their feed. Rights holders can request removal — copyright & takedown policy